Navigation Links
Carl Zeiss faces New Competition from Haag-Streit, Nidek and Topcon in the $600 Million Diagnostic Ophthalmic Device Market, reports iData Research
Date:11/11/2013

Vancouver, BC (PRWEB) November 11, 2013

iData Research, the leading global authority in medical device and pharmaceutical market research, has recently published a report for the U.S. diagnostic ophthalmic device markets. The report estimates a combined market value of $597 million and growing; expected to reach nearly $800 million by 2020. These markets include optical coherence tomographers (OCTs), fundus cameras, slit lamps, perimeters, tonometers, autorefractors and keratometers, binocular indirect ophthalmoscopes, ophthalmic ultrasound systems, wavefront aberrometers, corneal topographers and optical biometers.

Fast-Growing Market: OCT

Optical coherence tomography (OCT) is experiencing double-digit growth due to strong sales of combination OCT devices such as OCT with built-in fundus cameras and OCT scanning laser ophthalmoscopes. “More than half of devices currently sold are combination devices. In fact, the amalgamation of different tools is a widespread phenomenon in the U.S. ophthalmics market,” says Dr. Kamran Zamanian, CEO of iData. “In addition, our research covers autorefractors combined with keratometers or non-contact tonometers, amongst others.” Growth is expected to continue over the forecast period, with combination OCT devices accounting for an increasing share of the overall market.

Increased Competition

The market for optical biometry devices is also growing as the U.S. population ages and the number of cataract procedures increase. As a result, new optometry practices are opening and existing practices are making investments to expand their capacity necessitating the purchase of biometry equipment.

Carl Zeiss has traditionally been the leader of both the U.S. and European optical biometry market with their pioneering device, IOL Master™. Currently, they hold over three quarters of the U.S. market for optical biometers. This represents a slight decline as their main competitor, Haag-Streit shows market share gains. In the near future there will be additional pressure on Carl Zeiss to maintain its market share. Established competitors in Europe, Nidek and Topcon, are currently waiting for FDA approval. These two new entrants into the U.S. are expected to generate aggressive competition.

The information above is derived from a global report series entitled Markets for Diagnostic Ophthalmic Devices, which includes market analysis for the U.S., Germany, France, U.K., Italy, Spain, Benelux, Scandinavia, Portugal, Austria, and Switzerland.

Click here for a free synopsis of the U.S. Markets for Diagnostic Ophthalmic Devices report.

About iData Research
iData Research is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers market research in:
Anesthesia
Cardiology
Cosmetic surgery
Dental
Diabetes
Drug-delivery
Laparoscopy
Orthopedics
Urology
Vascular-access

Read the full story at http://www.prweb.com/releases/2013/11/prweb11317865.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Scientists uncover multiple faces of deadly breast cancer
2. UCLA study to determine if copper surfaces can reduce hospital-acquired infections
3. Scientists Spot 5 Genes That Help Shape Faces
4. Home Sales 19 Consecutive Monthly Gain Faces 2013 Wild Cards
5. Why do age-related macular degeneration patients have trouble recognizing faces?
6. Implicit race bias increases the differences in the neural representations of black and white faces
7. Difficulty in recognizing faces in autism linked to performance in a group of neurons
8. Copper surfaces reduce the rate of health care-acquired infections in the ICU
9. Faces Orthodontics Announces Availability of AcceleDent Technology that Cuts Braces Time in Half
10. Faces of Juicing: Fun and Easy Visual Juicing Recipes Now Available for Kindle or Full Color Print
11. Women Better at Remembering Faces, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... 23, 2017 , ... Goodcents Deli Fresh Subs today announced the opening of ... SW 21st St. Topeka, Kan. 66604 (near 21st and Gage). It is owned and ... three other locations in the Topeka and Bonner Springs, Kan. area. , “Goodcents ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia ... Sept. 18 to 20. , The two-day conference is focused on advancing scientific ... of improving patients’ lives and eliminating racial breast cancer-related disparities. The conference theme ...
(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased ... separator supplier for CDA members. As part of the amalgam separator endorsement, all CDA ... saving more than $400 off the retail value. This partnership between PureLife and CDA ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus in Northern Ireland is ... 3 pm to present to graduate students exciting new and innovative hope research based ... led by The Health Improvement Service of the Western Health & Social Care Trust ...
(Date:6/23/2017)... ... 2017 , ... All-Star Insurance, a family managed agency that offers insurance management ... announcing the launch of a new charity drive to benefit women in the area ... reveal that an estimated 252, 710 new cases of invasive or high risk breast ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: